Is general practitioner involvement in the initiation of opioids for chronic non-cancer pain associated with opioid dose and concurrent drug use?
Objective Is the involvement of the regular general practitioner (GP) in the decision to initiate opioid treatment for chronic non-cancer pain (CNCP) associated with two main risk factors for serious adverse events: increased opioid dose and the concomitant use of prescribed benzodiazepines or benzo...
Saved in:
| Main Authors: | Trond Høibø, Svetlana Skurtveit, Torgeir Gilje Lid |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-01-01
|
| Series: | Scandinavian Journal of Primary Health Care |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/02813432.2024.2404053 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opioid and/or Psychotropic Use Increases Intraprocedural Sedation Drug Requirements
by: Sreeja Sanampudi, et al.
Published: (2022-04-01) -
Trends in Opioid and Non-opioid Prescriptions in Austria (2016–2021): A Nationwide Study on Utilization and Concomitant Benzodiazepine Use
by: Aylin Bilir, et al.
Published: (2025-05-01) -
Experiences with healthy eating among individuals with opioid dependence: insights from a dietary assessment
by: Mohammed Khalid Al-Shibli, et al.
Published: (2025-06-01) -
Mothers with Concurrent Opioid and Cocaine Use and Neonatal Opioid Withdrawal Syndrome
by: Divya Rana, et al.
Published: (2025-07-01) -
Opioid analgesics for chronic noncancer pain in patients prescribed opioid agonist therapy or with opioid use disorder: A systematic review
by: Vahid Ashoorion, et al.
Published: (2025-12-01)